The Effect of Art Therapy on Patients With Stroke
The Effect of Art Therapy on Cognitive Ability, Arm Activity and Mental Health Status in Patients With Stroke
1 other identifier
interventional
60
1 country
1
Brief Summary
Stroke can affect the physical, emotional and social aspects of the patient and their family members. It is the main cause of complex disability, with a high number of people living with its effects. Stroke can result in impairments in motor function, language, cognition, sensory processing, cognition, and emotional disturbances, which can affect the performance of functional activities and mental health status. Getting patients involved in art therapy (AT) class has shown to alleviate stress and promote a sense of wellbeing, which can aid their recovery and rehabilitation. The benefits of art therapy for people living with different health conditions worldwide have been reported, however, its effect on Egyptian patients with stroke has been neglected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2019
CompletedFirst Posted
Study publicly available on registry
July 30, 2019
CompletedStudy Start
First participant enrolled
December 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
August 14, 2025
August 1, 2025
1.5 years
July 26, 2019
August 11, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
The Montreal Cognitive Assessment (MOCA)
The Montreal Cognitive Assessment is a 16-item screening assessment for mild cognitive impairment. It is widely used in stroke survivors and assesses performance attention, concentration, executive functions, memory, language, visual-constructional skills, conceptual thinking, calculations and orientation. The maximum score is 30 and scores of under 26 indicate cognitive impairment.
3 weeks
The Hospital Anxiety and Depression Scale (HADS)
This measurement consists of two subscales: Anxiety subscale (HADS-A) and a depression subscale (HADS-D) with 14 intermingled items. Each item is rated on a four-point scale of 0-3, giving maximum scores of 21 for anxiety and depression respectively. Scores of 11 or more on either subscale are considered as significant 'case' of psychological comorbidity, a score of 8-10 as borderline while a score of 7 or below is considered as normal.
3 weeks
The Arm Activity (ArmA) Measure
The ArmA measure is a patient and/or career-reported 20-item measure of difficulty in passive and active hemiparetic arm function. It consists of a seven-item passive function subscale, and 13-item active function subscale. Using a Likert scoring system between zero (no difficulty) and four (unable to do task). The passive function subscale scores range from zero (high function) to 28 and the active function subscale scores range from zero (high function) to 52.
3 weeks
Secondary Outcomes (2)
The Roger's Happy Sad face
pre and post each session/3 weeks
Self-efficacy and satisfaction for Art
3 weeks
Study Arms (2)
Study group
EXPERIMENTALThe intervention group (n = 30) will receive Routine Hospital Management (RHM), conventional rehabilitation activity and AT (painting, coloring, listening to music and Hand Therapy Ball Exercises). Overall 9 sessions over a period of three weeks will be performed and each session will take around 30 min.
Control group
NO INTERVENTIONThe control group (n = 30) will receive only the Routine Hospital Management (RHM) and the department conventional rehabilitation activity.
Interventions
Art therapy including coloring, painting and listening to music
Eligibility Criteria
You may qualify if:
- able to sit upright, supported or unsupported,
- oriented to time and place by using the adapted Arabic Memory Screening Test,
- able to perform at least two of the following skills: drinking from a cup, eating with a spoon and taking money from a purse by the affected arm, and
- will stay in the stroke unit to at least 4 days (for receiving three sessions out of all sessions) before discharge,
You may not qualify if:
- diagnosis of transient ischemic attack or brain stem stroke;
- unconscious;
- unable to provide informed consent;
- hemodynamical unstable medical conditions, including fever;
- serious infectious diseases, for example, viral hepatitis or HIV; and/or
- severe dementia or uncontrolled psychiatric problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Unit of stroke and cerebral vascular disease treatment
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 26, 2019
First Posted
July 30, 2019
Study Start
December 30, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
August 14, 2025
Record last verified: 2025-08